<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 8-hydroxy-2'-deoxyguanosine (8-OHdG), presently the most popular marker for oxidative DNA damage, level has been reported to be elevated in patients with various <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, urinary 8-OHdG was examined in 44 patients with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> (13 malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 11 adult T cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ATL), 10 <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, and 10 <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>)) by an enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="2" pm="."><plain>The pre-therapy level of urinary 8-OHdG in ATL patients was significantly elevated compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (25.3+/-12.9 vs. 11.9+/-7.3 ng/mg, P&lt;0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>Although patients with <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> also showed higher urinary 8-OHdG levels than <z:mpath ids='MPATH_458'>normal</z:mpath> controls, the differences were not significant </plain></SENT>
<SENT sid="4" pm="."><plain>However, two patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) having extreme <z:mp ids='MP_0000220'>monocytosis</z:mp> and <z:mp ids='MP_0000219'>neutrophilia</z:mp> showed exceptionally high urinary 8-OHdG levels (161.0 and 218.9 ng/mg) </plain></SENT>
<SENT sid="5" pm="."><plain>Urinary 8-OHdG excretion increased transiently with chemotherapy, and this fluctuation was significant irrespective of the disorder (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients with high LDH, advanced stage, poor performance status or International Prognostic Index (IPI) of high/high-intermediate risk had significantly elevated urinary 8-OHdG levels (P&lt;0.05-&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>These latter results suggest that urinary 8-OHdG may be a reliable prognostic marker in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients and should encourage large scale and long term follow up studies </plain></SENT>
</text></document>